Stage‐specific depletion of myosin A supports an essential role in motility of malarial ookinetes

Summary Functional analysis of Plasmodium genes by classical reverse genetics is currently limited to mutants that are viable during erythrocytic schizogony, the pathogenic phase of the malaria parasite where transfection is performed. Here, we describe a conceptually simple experimental approach to...

Full description

Saved in:
Bibliographic Details
Published inCellular microbiology Vol. 13; no. 12; pp. 1996 - 2006
Main Authors Siden‐Kiamos, Inga, Ganter, Markus, Kunze, Andreas, Hliscs, Marion, Steinbüchel, Marion, Mendoza, Jacqueline, Sinden, Robert E., Louis, Christos, Matuschewski, Kai
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.12.2011
Hindawi Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Summary Functional analysis of Plasmodium genes by classical reverse genetics is currently limited to mutants that are viable during erythrocytic schizogony, the pathogenic phase of the malaria parasite where transfection is performed. Here, we describe a conceptually simple experimental approach to study the function of genes essential to the asexual blood stages in a subsequent life cycle stage by a promoter‐swap approach. As a proof of concept we targeted the unconventional class XIV myosin MyoA, which is known to be required for Toxoplasma gondii tachyzoite locomotion and host cell invasion. By placing the corresponding Plasmodium berghei gene, PbMyoA, under the control of the apical membrane antigen 1 (AMA1) promoter, expression in blood stages is maintained but switched off during transmission to the insect vector, i.e. ookinetes. In those mutant ookinetes gliding motility is entirely abolished resulting in a complete block of life cycle progression in Anopheles mosquitoes. Similar approaches should permit the analysis of gene function in the mosquito forms that are shared with the erythrocytic stages of the malaria parasite.
Bibliography:These authors contributed equally.
Present address: Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA.
Present address: European Molecular Biology Laboratory, 69117 Heidelberg, Germany.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1462-5814
1462-5822
DOI:10.1111/j.1462-5822.2011.01686.x